Premier Integrated Labs is leading efforts to advance early diagnosis and understanding of Alzheimer’s disease in Malaysia – a critical step in improving outcomes for patients and families affected by the condition.
On 22 April 2025, Premier Integrated Labs (PIL) launched a nationwide Continuing Medical Education tour in Penang, in collaboration with Mayo Clinic Laboratories and Eisai Co., Ltd.
The inaugural event brought together neurology specialists from both public and private hospitals to spotlight the importance of early detection and biomarker-based testing for Alzheimer’s.
Dr Jaron L from Mayo Clinic Laboratories highlighted the benefits of biomarker-driven diagnostics, while Dr Yew Keong Ng from Eisai shared insights into the evolving diagnostics landscape in Malaysia. The strong turnout underscored the clinical community’s shared commitment to tackling one of the most pressing neurological challenges of our time.
Separately, PIL also participated in a strategic session with YBhg Datuk Dr Muhammad Radzi Abu Hassan, former Director-General of Health, Malaysia Ministry of Health, to present updates on the ongoing study “Whole Exome Sequencing in Late-Onset Alzheimer’s Disease (LOAD) in Peninsular Malaysia.” The study seeks to uncover genomic markers and better understand the clinical characteristics of LOAD among local patients.
Representing PIL were CEO Hareeff Muhammed, Sayyidi Hamzi, and Dr Zubaidah, alongside collaborators Dr Hans Prakash (Institute for Medical Research) and Dr Cheah Wee Kooi (Hospital Taiping).
These initiatives reflect PIL’s dedication to fostering clinical collaboration, advancing diagnostics, and driving evidence-based care in the fight against Alzheimer’s disease.
Related Stories
Mount Elizabeth’s Revitalisation Sets a New Benchmark for Patient-Centred Care in the Region
IHH Healthcare Singapore is strengthening its legacy of care through the revitalisation of Mount Elizabeth Hospital (MEH), a flagship institution that has supported patients from Singapore, Indonesia and across the region for more than 45 years.
Fortis Charts the Future of Haematology
On 22 and 23 November, Fortis Memorial Research Institute, Gurugram (Fortis Gurugram) hosted HemeNext 1.0, a pioneering national conference exploring how genomics, artificial intelligence, robotics and advanced cell therapies are reshaping haematology and infectious disease care across India.
Proudly the First: IHH Healthcare Singapore Achieves Full National Electronic Health Record Participation
IHH is proud to be the first private healthcare group in Singapore with all four hospitals fully contributing to the National Electronic Health Record (NEHR), reflecting our steadfast commitment to advancing continuity of care and building a more connected, patient-centred healthcare ecosystem.
Parkway Shanghai Hospital and Shanghai General Hospital Establish Strategic Partnership to Advance High-Quality Healthcare
Fortis Launches Adayu, a Hospital Dedicated to Specialised Mental Health Care
